Copyright
©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3099-3102
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3099
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3099
Figure 1 Study design.
Figure 2 AgNOR-PI in OTCG before and after 1 year of IFN treatment.
Figure 3 Incidence of HCC according to AgNOR-PI.
Figure 4 Percentage of HCC according to response to IFN.
Figure 5 Survival probability evaluated by Kaplan-Mayer model.
- Citation: Francesco A, Esterita A, Giovanni N, Davide T, Silvia G, Anna M, Francesca L, Marco M, Mariarosa T, Antonio C, Constance M, Davide F, Enrico R, Massimo D, Giuseppe M. Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis. World J Gastroenterol 2004; 10(21): 3099-3102
- URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3099.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3099